This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Mcmurray JJV, Andersson FL, Stewart S, Svensson K, Solal AC, Dietz R, Vanhaecke J, van Veldhuisen DJ, Östergren J, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, CHARM Investigators and Committees.Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal 27: 1447-1458, No. 12, Jun 2006
Rights and permissions
About this article
Cite this article
Candesartan an attractive adjunct for HF. Pharmacoecon. Outcomes News 510, 4 (2006). https://doi.org/10.2165/00151234-200605100-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605100-00010